feed,title,long_url,short_url
SeekingAlpha,Altimmune stock slumps ~35% amid phase 2 trial data of obesity drug pemvidutide,https://seekingalpha.com/news/3949389,
SeekingAlpha,Foot Locker stock attracts bull rating from Evercore ISI,https://seekingalpha.com/news/3949392,
SeekingAlpha,Peloton edges up as JMP Securities estimates strong Amazon sales,https://seekingalpha.com/news/3949391,
SeekingAlpha,Oric gains as Guggenheim upgrades on near-term catalysts,https://seekingalpha.com/news/3949390,
